BRIEF-Organovo and Viscient Biosciences collaborate to develop custom research platform for studying liver disease

Spread the love

Nov 6 (Reuters) – Organovo Holdings Inc:

* Organovo and Viscient Biosciences collaborate to develop custom research platform for studying liver disease

* Says Viscient is targeting early discovery work for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.